GEHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
GE Healthcare Technologies Inc (GEHC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has positive long-term growth potential and analysts maintain optimistic price targets, the current technical indicators, declining financial performance, and hedge fund selling suggest waiting for a better entry point.
The MACD is negatively expanding (-0.537), RSI is at 23.213 (neutral zone), and moving averages are converging. The stock is trading near its S1 support level of 77.103, with resistance at 81.519. The overall trend is bearish, with a -2.42% regular market change and a -1.97% pre-market change.
Analysts have raised price targets recently, with firms like Argus and Stifel maintaining Buy ratings. The company has established a $0.5 billion revolving credit facility to support healthcare providers, which could enhance its operational flexibility.
Hedge funds are selling, with a 129.92% increase in selling activity over the last quarter. Financial performance in Q4 2025 showed a decline in net income (-18.31% YoY), EPS (-17.83% YoY), and gross margin (-7.22% YoY). Technical indicators suggest a bearish trend, and the options market reflects bearish sentiment.
In Q4 2025, revenue increased by 7.13% YoY to $5.698 billion. However, net income dropped by 18.31% YoY to $589 million, EPS fell by 17.83% YoY to 1.29, and gross margin decreased by 7.22% YoY to 39.68%. These declines indicate challenges in profitability despite revenue growth.
Analysts have recently raised price targets, with the highest being $105 (Jefferies) and the lowest at $85 (Morgan Stanley). The consensus sentiment is positive, with several firms maintaining Buy or Overweight ratings, citing solid execution and a positive 2026 outlook.
